Veterinary teams adopted an emergency mindset when the pandemic first hit. But we’re in the “new normal” now—and teams may need to adjust clients’ expectations.
Pandemic-related pet adoptions are definitely up in the US . . . but maybe not as much as some news reports suggest.
This week: Congress bans private ownership of big cats and Brazil taps dogs to sniff out COVID. Plus, how do robotic therapy dogs compare to the real thing?
This week: The FDA investigates reports of aflatoxin in pet food, dog racing to end in Florida, and the first year of pet ownership is the hardest.
We know humans can give SARS-CoV-2 to animals. But can animals give it to humans? According to Dutch researchers, the answer is . . . yes.
For most of your AAHA colleagues, the answer is “No.” But for some, it’s “Yes.” The rollout’s still a mess, but there are bright spots.
This week: What appears to be cancer in English bulldogs might be something else, Walmart and Nationwide team up for new Rx program, and mammal-airplane collisions are on the rise.
This week: COVID-sniffing dogs to work NBA games, Arkansas house cat tests positive for COVID, and the toll climbs higher in the Sportmix pet food aflatoxin recall.
This week: COVID PPE is killing wildlife, the science behind French rabbits’ unique gait, and another recall from Midwestern Pet Foods (but not for aflatoxin).
The process of sourcing veterinary pharmaceuticals can be challenging. Veterinarians and their purchasing managers must find a balance between drug quality, cost, availability, and patient needs.